NASDAQ:CORZ
Core Scientific, Inc./tx
Core Scientific, Inc./tx's revenue fell 37.5% in fiscal 2025 to $319.0M. The diluted share count rose 24.3%.Summary generated from Core Scientific, Inc./tx's SEC filings. Latest annual report filed Mar 2, 2026.
Key statistics
Fiscal 2025 from SEC filings. MethodologyRevenue (FY25)$319.0M
Revenue growth−37.5%
Revenue, 5-yr CAGR+39.5%
Net margin−90.5%
Return on equityn/a
Share count change+24.3%
Financials
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 544 | 640 | 502 | 511 | 319 |
| Net income | 47 | −2,146 | −246 | −1,438 | −289 |
Recent filings
- 4Insider transaction report
Oct 7, 2026 - 4Insider transaction report
Oct 5, 2026 - 8-KRegulation FD disclosure
Sep 10, 2026 - 8-KEntry into a material agreement
Aug 27, 2026 - 8-KRegulation FD disclosure
Aug 14, 2026 - 8-KDirector or officer change
Jul 29, 2026 - 10-QQuarterly report for the period ended Jun 30, 2026
Jul 28, 2026 - 8-KResults of operations and financial condition
Jul 28, 2026